How to appeal a Blue Cross NC endocrine (non-diabetes) denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Blue Cross NC-specific note: BCBS licensee for North Carolina (~4.3M members). Prime Therapeutics PBM. NC DOI oversight. Blue Premier is the high-profile value-based care program. Recently divested some Medicaid business; Healthy Blue (joint venture with Elevance) handles NC Medicaid.

What Blue Cross NC's policy requires for endocrine (non-diabetes)

Cited policy: BCBS Pharmacy Policy — Crinecerfont (Crenessity)

Classic CAH genotype-confirmed. Adolescents and adults. Glucocorticoid dose minimization goal.

How Blue Cross NC denies endocrine (non-diabetes) — and how to counter it

Where Blue Cross NC pushes back: 1) 'Experimental / new drug'; 2) GC dose 'adequate'; 3) Pediatric coverage limitations.

Counter-arguments that hold up: FDA approved Dec 2024 — first new CAH treatment in decades. Cite CAHtalyst Adult + Pediatric trials. Endocrine Society 2018 CAH guidelines endorse glucocorticoid minimization goal. Document supraphysiologic GC dose + adverse effects (Cushingoid features, BMD loss, growth impairment in peds, metabolic syndrome).

What Blue Cross NC typically denies for endocrine (non-diabetes)

Across Blue Cross NC's commercial and Medicare books, denials cluster around a small number of patterns. For endocrine (non-diabetes), expect:

• Step therapy via Prime Therapeutics
• Blue Premier value-based arrangement disputes
• Out-of-network reductions
• Specialty drug PA

Treatments most often denied in this category

These are the endocrine (non-diabetes) treatments most often flagged for prior auth, step therapy, or medical necessity review:

• TRT
• Tepezza (TED)
• Crenessity (CAH)
• Isturisa (Cushing's)
• Recorlev
• Mycapssa

How to submit the appeal to Blue Cross NC

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Blue Cross NC cited in the denial.
3. File the appeal through Blue Cross NC's portal (members: https://www.bluecrossnc.com ; providers: https://www.bluecrossnc.com/providers). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In NC, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Blue Cross NC's prior-authorization criteria by drug: Blue Cross NC PA criteria on ApprovalHelp.